Holen Sie sich die Stockscreener-App
5.1774
10.16%
0.4774
Rain Enhancement Technologies Holdco Inc Aktie (RAIN) Neueste Nachrichten
Dell transforms AI PC portfolio for anywhere productivity - Quantisnow
Stock market today: NextNav -22.28%, Intrusion -19.76% among biggest losers in early trading - Business Upturn
Stock market today: AEON Biopharma saw gain of 255.62% while SciSparc increased by 89.77% in early trading - Business Upturn
Bad weather alert for Sabah, Sarawak and Labuan - The Malaysian Reserve
Stock market news: Dogness (International) -25.96%, Heartcore Enterprises -21.48% among biggest losers during mid day trading - Business Upturn
FTSE 100 Holds Steady as Energy Shares Offset Sectoral Declines – Market - HPBL
FTSE 100 Pauses After Weekly Surge Amid Energy Gains and Retail Challenges – Market - HPBL
FTSE 100 Rallies While NASDAQ 100 Wavers: A Tale of Two Indices – Market - HPBL
DAX Begins 2025 Strong: Can It Break the 20,523 Record High? – Market - HPBL
Latham, Paul Weiss, Debevoise Land on Year-End Big Deals. But Geopolitical Uncertainty Could Slow M&A Growth in 2025 - Law.com International
Deal Watch: Latham, Paul Weiss, Debevoise Land on Year-End Big Deals. Plus, Mixed Messages for 2025 M&A - Law.com
Stock market news: Rain Oncology +371.17%, SuperCom +75.93% among top gainers during mid day trading - Business Upturn
Stock market news: Neumora Therapeutics down by 80.75% while N2OFF surged by 333.47% during mid day trading - Business Upturn
Spain IBEX 35 Rises on Energy and Consumer Goods Gains, Gold and Oil Prices Surge – Market - HPBL
Fidelity MSCI Financials Index ETF (FNCL): A Cost-Effective Gateway to the Financial Sector – Market - HPBL
Fidelity Boosts Valuation of Elon Musk X by 32%, Signaling Renewed Optimism – Market - HPBL
JPMorgan Global Growth & Income Plc Issues 200,000 Shares, Raising Capital for Future Strategy - HPBL
Neumora Therapeutics and Other Stocks Suffer Major Losses as Market Faces Declines - HPBL
Rain Oncology, Alset Inc., and Other Stocks Surge as Investors Eye Market Opportunities - HPBL
Neumora Therapeutics, Rain Oncology, and Carmell Corporation: Stock Volatility Highlights Major Market Moves - HPBL
Tech Stocks Display Mixed Performance in Early Market Trading: Tesla Drops While MicroStrategy Soars - HPBL
Trump Media & Technology Group (DJT) Sees Modest Stock Rise Amid Volatility – Market - HPBL
3 Vanguard ETF to Buy in 2025 for Higher Yields and Lower P/E Ratios Amid Market Volatility - HPBL
Stock market today: Neumora Therapeutics down by 81.14% while Rain Oncology surged by 676.86% in early trading - Business Upturn
Stock market today: Rain Oncology +603.31%, Alset +103.93% among top gainers in early trading - Business Upturn
Rain Enhancement Technologies Completes Business Combination with Coliseum Acquisition - Defense World
Tuesday’s Insider Activity: Top Buys and Sells in US Stocks Revealed - Investing.com Nigeria
Tuesday's Insider Activity: Top Buys and Sells in US Stocks Revealed - Investing.com Australia
Rain enhancement technologies investor Paul Dacier buys $100k in stock By Investing.com - Investing.com India
Rain Enhancement Technologies Goes Public on Nasdaq, Promising 16% More Rainfall with Breakthrough Tech - StockTitan
U.S. Stock Market Nears Historic Finish as S&P 500 Set for Strong Year-End Gains – Market - HPBL
CrowdStrike Holdings (CRWD): A Cybersecurity Leader Positioned for Strong Growth in 2025 - HPBL
Nasdaq 100, Dow Jones, and S&P 500 Technical Analysis: Market Trends Heading into 2025 - HPBL
Wall Street Holiday Schedule: US Stock Markets Close Early on December 31, 2024 for New Year Celebration - HPBL
Indian Stock Market to Stay Open on New Year Day 2025: Here What You Need to Know - HPBL
Wall Street Set for Modest Gains on Final Day of 2024 Amid Strong Year-End Performance – Market - HPBL
Ather Energy IPO: What You Need to Know About Its Market Debut and Future Plans – Market - HPBL
US Stocks Surge to Historic Heights in 2024: S&P 500’s Back-to-Back 20% Gains and What It Means for Investors - HPBL
Boeing Stock Drops After Jeju Air Boeing 737-800 Crash in South Korea, Killing 179 People – Market - HPBL
Spanish Stock Market Set to Close 2024 Strong Amid Global Uncertainty – Market - HPBL
Coliseum Acquisition Corp. Faces Nasdaq Trading Suspension - Defense World
Coliseum Acquisition Corp. faces Nasdaq delisting, extends merger deadline By Investing.com - Investing.com South Africa
Coliseum Acquisition Corp. faces Nasdaq delisting, extends merger deadline - Investing.com India
MITAU stock touches 52-week low at $9.67 amid market shifts - Investing.com
Coliseum Acquisition Corp. Announces Redemption Reversals and Potential Purchases of Public Shares - Defense World
Biliary Tract Cancer Market Expected to Experience Major Growth by 2034, According to DelveInsight - EIN News
Coliseum Acquisition Corp. allows redemption reversal ahead of meetings - Investing.com
Coliseum Acquisition Corp. enters definitive agreement ahead of merger By Investing.com - Investing.com South Africa
Germ Cell Tumors Market to Register Significant Growth at a CAGR of 5.5% by 2034 | DelveInsight - The Malaysian Reserve
MET Targeting Therapies Market Set for Significant Growth by 2034: Key Trends and Insights | DelveInsight - GlobeNewswire
Coliseum Acquisition Corp. Reminds Shareholders to Vote in Connection with Business Combination and Extension - Business Wire
CTLA-4 Inhibitors Market to Advance at Moderate CAGR During the Study Period (2020-2034) | DelveInsight - The Malaysian Reserve
Coliseum Acquisition Corp. and Rain Enhancement Technologies, Inc. Announce SEC Filing Effectiveness for Business Combination - Defense World
Coliseum Acquisition Corp. and Rain Enhancement Technologies, Inc. Announce Effectiveness of Registration Statement for Proposed Business Combination - Business Wire
Precision Oncology Market is growing at a CAGR of 9.95% in the forecast period (2024-2031) - openPR
Dr Reddy's launches Toripalimab to treat nasopharyngeal cancer in India - Business Standard
AffyImmune Appoints Deyaa Adib, MD as Chief Medical Officer - PR Newswire
S&P 500 ESG (ESG) QuotePress Release - The Globe and Mail
S&P 500 Value (IVX) QuotePress Release - The Globe and Mail
Costco Wholesale (COST-Q) QuotePress Release - The Globe and Mail
S&P 500 Communication Services [Sector] (SRTS) QuotePress Release - The Globe and Mail
TSX Global Base Metals EW Index (TXBE) QuotePress Release - The Globe and Mail
Non-small Cell Lung Cancer Treatment Market 2032: Clinical - openPR
4.33%
1.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):